These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 31350957

  • 1. Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using 18FDG PET/ CT with Standardized Protocol.
    Fatima N, Zaman MU, Zaman A, Zaman U, Tahseen R, Zaman S.
    Asian Pac J Cancer Prev; 2019 Jul 01; 20(7):2003-2008. PubMed ID: 31350957
    [Abstract] [Full Text] [Related]

  • 2. Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation.
    Arnett ALH, Merrell KW, Macintosh EM, James SE, Nathan MA, Shen KR, Ravi K, Neben Wittich MA, Haddock MG, Hallemeier CL.
    J Thorac Oncol; 2017 Jan 01; 12(1):121-128. PubMed ID: 27569732
    [Abstract] [Full Text] [Related]

  • 3. Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response.
    Cabral F, Cruz A, Casaca R, Monteiro C, Ramos P, Pedro C, Brandão F, Fonseca R, Ratão P, Salgado L, Pinto I, Abecasis N.
    Cancer Radiother; 2020 Dec 01; 24(8):834-841. PubMed ID: 33191120
    [Abstract] [Full Text] [Related]

  • 4. 18F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer.
    Mantziari S, Pomoni A, Prior JO, Winiker M, Allemann P, Demartines N, Schäfer M.
    BMC Med Imaging; 2020 Jan 22; 20(1):7. PubMed ID: 31969127
    [Abstract] [Full Text] [Related]

  • 5. PET/CT in the evaluation of treatment response to neoadjuvant chemoradiotherapy and prognostication in patients with locally advanced esophageal squamous cell carcinoma.
    Yuan H, Tong DK, Vardhanabhuti V, Law SY, Chiu KW, Khong PL.
    Nucl Med Commun; 2016 Sep 22; 37(9):947-55. PubMed ID: 27145438
    [Abstract] [Full Text] [Related]

  • 6. Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
    Tan S, Kligerman S, Chen W, Lu M, Kim G, Feigenberg S, D'Souza WD, Suntharalingam M, Lu W.
    Int J Radiat Oncol Biol Phys; 2013 Apr 01; 85(5):1375-82. PubMed ID: 23219566
    [Abstract] [Full Text] [Related]

  • 7. FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy.
    Huang YC, Lu HI, Huang SC, Hsu CC, Chiu NT, Wang YM, Chiu YC, Li SH.
    BMC Med Imaging; 2017 Jan 05; 17(1):1. PubMed ID: 28056868
    [Abstract] [Full Text] [Related]

  • 8. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
    Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD.
    Ann Surg; 1999 May 05; 229(5):729-37; discussion 737-8. PubMed ID: 10235532
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinoma.
    Ma JB, Chen EC, Song YP, Liu P, Jiang W, Li MH, Yu JM.
    Asian Pac J Cancer Prev; 2013 May 05; 14(4):2477-81. PubMed ID: 23725159
    [Abstract] [Full Text] [Related]

  • 10. Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.
    Gerbaudo VH, Killoran JH, Kim CK, Hornick JL, Nowak JA, Enzinger PC, Mamon HJ.
    Ann Nucl Med; 2018 Apr 05; 32(3):165-174. PubMed ID: 29332233
    [Abstract] [Full Text] [Related]

  • 11. The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy.
    Mattoli MV, Massaccesi M, Castelluccia A, Scolozzi V, Mantini G, Calcagni ML.
    Radiat Oncol; 2017 Jan 05; 12(1):4. PubMed ID: 28057034
    [Abstract] [Full Text] [Related]

  • 12. Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma.
    Elliott JA, O'Farrell NJ, King S, Halpenny D, Malik V, Muldoon C, Johnston C, Reynolds JV.
    Br J Surg; 2014 Dec 05; 101(13):1702-11. PubMed ID: 25351460
    [Abstract] [Full Text] [Related]

  • 13. [Correlation between PET-CT 18FDG uptake in primary lesions and clinicopathological parameters in esophageal carcinoma patients].
    Feng R, Li MH, Kong L, Shi F, Yang GR, Yu JM.
    Zhonghua Zhong Liu Za Zhi; 2009 Jun 05; 31(6):452-4. PubMed ID: 19950557
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemoradiation for esophageal cancer : Surgery improves locoregional control while response based on FDG-PET/CT predicts survival.
    Hegemann NS, Koepple R, Walter F, Boeckle D, Fendler WP, Angele MK, Boeck S, Belka C, Roeder F.
    Strahlenther Onkol; 2018 May 05; 194(5):435-443. PubMed ID: 29349603
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer.
    Gabriel E, Alnaji R, Du W, Attwood K, Kukar M, Hochwald S.
    Ann Surg Oncol; 2017 Jun 05; 24(6):1739-1746. PubMed ID: 28058562
    [Abstract] [Full Text] [Related]

  • 18. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.
    Yu W, Fu XL, Zhang YJ, Xiang JQ, Shen L, Chang JY.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):e759-65. PubMed ID: 21470788
    [Abstract] [Full Text] [Related]

  • 19. Nodal FDG-PET/CT uptake influences outcome and relapse location among esophageal cancer patients submitted to chemotherapy or radiochemotherapy.
    Jimenez-Jimenez E, Mateos P, Ortiz I, Aymar N, Roncero R, Gimenez M, Pardo J, Sabater S.
    Clin Transl Oncol; 2019 Sep 01; 21(9):1159-1167. PubMed ID: 30661172
    [Abstract] [Full Text] [Related]

  • 20. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
    Kukar M, Alnaji RM, Jabi F, Platz TA, Attwood K, Nava H, Ben-David K, Mattson D, Salerno K, Malhotra U, Kanehira K, Gannon J, Hochwald SN.
    JAMA Surg; 2015 Jun 01; 150(6):555-62. PubMed ID: 25902198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.